Science · 1996 · 323 citations · 18 references
HistocompatibilityPeptide EngineeringEnhanced DissociationHla ImmunogeneticsImmunologyMolecular BiologyAntigen ProcessingPeptide DissociationImmunotherapyProtein FoldingBiochemistryHuman Leukocyte AntigenAutoimmunityNon-peptide LigandOther PeptidesNatural SciencesPeptide LibraryPeptide SynthesisProtein EngineeringMedicineAntigenic Peptides
Human leukocyte antigen (HLA)-DM is a critical participant in antigen presentation that catalyzes the release of class II-associated invariant chain-derived peptides (CLIP) from newly synthesized class II histocompatibility molecules, freeing the peptide-binding site for acquisition of antigenic peptides. The mechanism for the selective release of CLIP but not other peptides is unknown. DM was found to enhance the rate of peptide dissociation to an extent directly proportional to the intrinsic rate of peptide dissociation from HLA-DR, regardless of peptide sequence. Thus, CLIP is rapidly released in the presence of DM, because its intrinsic rate of dissociation is relatively high. In antigen presentation, DM has the potential to markedly enhance the rate of peptide exchange, favoring the presentation of peptides with slower intrinsic rates of dissociation.
18
Binding of immunogenic peptides to Ia histocompatibility molecules
Bruce Babbitt, Paul M. Allen, Gary R. Matsueda et al. · Nature · 1985 · 1.2K citations
Isolation and characterization of antigen-la complexes involved in T cell recognition
Søren Buus, Alessandro Sette, S M Colón et al. · Cell · 1986 · 466 citations